Market revenue in 2020 | USD 123.7 million |
Market revenue in 2028 | USD 220.7 million |
Growth rate | 7.5% (CAGR from 2020 to 2028) |
Largest segment | External beam radiationtherapy |
Fastest growing segment | Internal Beam Radiation Therapy |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
External beam radiationtherapy was the largest segment with a revenue share of 70.9% in 2020. Horizon Databook has segmented the Brazil radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Brazil is one of the emerging markets and offers lucrative growth opportunities for radiation oncology market. The incidence rate of the cancer is high in this country due to moderate standards of living, which increases the demand of advanced treatment options.
According to WHO, 84,992 new cases of prostrate cancer were diagnosed in 2018, and 16,730 individuals died due to this disease in Brazil. Furthermore, the rise in implementation of strategies such as collaborations and merger & acquisitions among the market players are expected to drive the market growth.
For instance, In June 2017, Koninklijke Philips N.V. and IBA Worldwide collaborated to introduce advanced diagnostics and proton therapy solutions in the Brazilian market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account